Skip to content
Screener

Delcath Systems DCTH Prepaid Clinical Trial Expenses Current

Prepaid Clinical Trial Expenses Current at other companies

Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$2.79M
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$2.79M
HTF
Heartflow, Inc.HTFL
$1.12M
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$1.21M+17.0%
RFL
Rafael Holdings, Inc.RFL
$381K
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$0+100%

Other financials

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$534.05M+44.1%
Enterprise value$489.01M+45.0%
P/E104.2×
P/S5.6×+0.3×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio9.8×-1.0×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept dcth:PrepaidClinicalTrialExpensesCurrent.

The source filing: Delcath Systems’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 9:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053956
(In thousands)June 30,2026December 31,2025
Clinical trial expenses$2,445$2,405
Insurance premiums371547
Professional services942804
Interest receivable328499
Licenses576613
Software1,331706
Taxes653696
Other333228

Item 1. Financial Statements

FAQ

What is Delcath Systems's prepaid clinical trial expenses current?
Delcath Systems (DCTH) reported prepaid clinical trial expenses current of $2.45M in Q2 2026.
How has Delcath Systems's prepaid clinical trial expenses current changed year-over-year?
Delcath Systems's prepaid clinical trial expenses current increased by 1.7% year-over-year, from $2.41M to $2.45M.
What is the long-term trend for Delcath Systems's prepaid clinical trial expenses current?
Over 4 years (2021 to 2025), Delcath Systems's prepaid clinical trial expenses current has grown at a 10.2% compound annual growth rate (CAGR), from $1.63M to $2.41M.
What does prepaid clinical trial expenses current mean?
Prepaid Clinical Trial Expenses Current as reported by Delcath Systems Inc.

Ask your AI about Delcath Systems's prepaid clinical trial expenses current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude